TietoEnator Medical develops integrated HIS in Denmark
Swedish information systems vendor TietoEnator Medical has completed development of its first healthcare data management product, which links legacy health information systems with x-ray and laboratory
Swedish information systems vendor TietoEnator Medical has completed development of its first healthcare data management product, which links legacy health information systems with x-ray and laboratory systems via a Web application using the distributed healthcare environment (DHE), a healthcare-specific application platform developed by GESI, an Italian healthcare information systems firm. DHE uses health information systems architecture (HISA), an EU standard, which integrates systems by allowing information that was fed into one system to be used by all other linked systems without reentry. Stockholm, Sweden-based TietoEnator demonstrated the systems capabilities to Danish politicians and two IT societies, Kobenhavns Amts Sygehusvaesen (KAS) and Hovedstadens Sygehusfaelleskab (H:S), on March 1.
The system was developed after 11 hospitals in Denmark joined with KAS and H:S in organizing a vendor competition to jump-start development of a healthcare product that would integrate legacy systems and streamline data management. The contract was awarded to TietoEnator, which worked in conjunction with GESI to build the system to specifications. If hospitals choose to purchase the new system, it will be installed this spring, according to H:S.
© 2000 Miller Freeman, Inc., a United News & Media company.
- Search again
- Homepage
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
